GlycoMimetics, Inc.
GlycoMimetics, Inc. Commences Phase 1 Clinical Trial of Lead Drug Candidate
Published in Healthcare Finance, Tax and Law Weekly, September 17th, 2008
"We are pleased to advance our lead drug candidate into clinical trials," said Rachel King, Chief Executive Officer of GlycoMimetics. "GMI-1070 possesses excellent drug-like properties and has demonstrated potency in pre-clinical studies of vaso-occlusive crisis as well as in other disease indications."
The Phase 1 trial will evaluate the safety and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- A.M. Best Co.
A.M. Best Affirms and Assigns Ratings to AMERIGROUP Corporation's HMO Subsidiaries - Abbott
Abbott to Present at Bank of America 38th Annual Investment Conference - Abigail Adams National Bancorp
Jeanne Delaney Hubbard Resigns from Her Positions with Abigail Adams National Bancorp - Abu Dhabi Media Company
Abu Dhabi Media Company Forms Imagenation Company to Produce Feature Films and Digital Content - Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals Completes Second Closing of Senior Convertible Debt Financing - AIDS Healthcare Foundation and CA Assembly Member Paul Krekorian's office
California Law to Compel Insurers to Cover Routine HIV Tests Is First in Nation - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
